Core Laboratories Inc. — Form 8-K Summary
Business context and reporting period
Core Laboratories Inc. filed a Form 8-K dated November 1, 2023, under Items 2.02 and 7.01. The filing reports that the company issued a press release announcing financial results for the third quarter of 2023. The provided filing text does not include the press release’s detailed results.
Financial metrics
The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, liquidity, operating metrics, or other third-quarter financial results.
Material changes versus the prior comparable period
No comparative financial data or quantified year-over-year or sequential changes are included in the provided filing text.
Dividend, outlook, risks, and unusual items
- The company announced a quarterly cash dividend of $0.01 per common share.
- Shareholders of record on November 13, 2023 were eligible for the dividend, which was payable December 4, 2023.
- The filing text does not provide guidance, an outlook, management commentary, risk updates, contingencies, or unusual items.
- The press release was furnished as Exhibit 99.1 and is not deemed filed for purposes of Section 18 of the Exchange Act, nor incorporated by reference except where expressly stated.
Key facts for investors to verify
- Review Exhibit 99.1 for the complete third-quarter 2023 financial results and comparisons.
- Verify revenue, earnings, cash flow, margins, debt, liquidity, and any adjusted or non-GAAP measures in the press release.
- Confirm the $0.01-per-share dividend record date of November 13, 2023 and payment date of December 4, 2023.
- Assess any guidance, operational commentary, risks, or contingencies disclosed in the omitted press release.